Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 462

1.

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.

Furmark T, Marteinsdottir I, Frick A, Heurling K, Tillfors M, Appel L, Antoni G, Hartvig P, Fischer H, Långström B, Eriksson E, Fredrikson M.

J Psychopharmacol. 2016 May 17. pii: 0269881116648317. [Epub ahead of print]

PMID:
27189957
2.

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A.

J Nucl Med. 2016 Jul;57(7):1071-7. doi: 10.2967/jnumed.115.168732. Epub 2016 Feb 16.

PMID:
26912447
3.

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A.

Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26.

4.

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.

Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A.

Sci Rep. 2015 Nov 10;5:16404. doi: 10.1038/srep16404.

5.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

PMID:
26401704
6.

Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study.

Rahman O, Takano A, Amini N, Dahl K, Kanegawa N, Långström B, Farde L, Halldin C.

Nucl Med Biol. 2015 Nov;42(11):893-8. doi: 10.1016/j.nucmedbio.2015.07.003. Epub 2015 Jul 15.

PMID:
26272268
7.

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

Frick A, Ahs F, Linnman C, Jonasson M, Appel L, Lubberink M, Långström B, Fredrikson M, Furmark T.

Transl Psychiatry. 2015 Jul 7;5:e597. doi: 10.1038/tp.2015.92.

PMID:
26151925
8.

Endogenous compounds labeled with radionuclides of short half-life-some perspectives.

Långström B, Karimi F, Watanabe Y.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):251-62. doi: 10.1002/jlcr.3033. Review.

PMID:
24285332
9.

Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET.

Appel L, Bergström M, Buus Lassen J, Långström B.

Eur Neuropsychopharmacol. 2014 Feb;24(2):251-61. doi: 10.1016/j.euroneuro.2013.10.007. Epub 2013 Oct 22.

PMID:
24239329
10.

PET-scan shows peripherally increased neurokinin 1 receptor availability in chronic tennis elbow: visualizing neurogenic inflammation?

Peterson M, Svärdsudd K, Appel L, Engler H, Aarnio M, Gordh T, Långström B, Sörensen J.

PLoS One. 2013 Oct 14;8(10):e75859. doi: 10.1371/journal.pone.0075859. eCollection 2013.

11.

Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.

Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, Långström B, Almkvist O, Nordberg A.

Neurobiol Aging. 2013 Nov;34(11):2465-81. doi: 10.1016/j.neurobiolaging.2013.04.027. Epub 2013 Jun 4.

PMID:
23759148
12.

Amyloid-β positron emission tomography imaging probes: a critical review.

Kepe V, Moghbel MC, Långström B, Zaidi H, Vinters HV, Huang SC, Satyamurthy N, Doudet D, Mishani E, Cohen RM, Høilund-Carlsen PF, Alavi A, Barrio JR.

J Alzheimers Dis. 2013;36(4):613-31. doi: 10.3233/JAD-130485. Review.

13.

Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Giandomenico V, Modlin IM, Pontén F, Nilsson M, Landegren U, Bergqvist J, Khan MS, Millar RP, Långström B, Borlak J, Eriksson B, Nielsen B, Baltzer L, Waterton JC, Ahlström H, Öberg K.

Neuroendocrinology. 2013;98(1):16-30. doi: 10.1159/000348832. Epub 2013 Jun 28.

14.

Molecular imaging in breast cancer.

Ruibal A, Benlloch JM, Olmos RV, Langstrom B.

J Oncol. 2012;2012:426260. doi: 10.1155/2012/426260. Epub 2012 Dec 29. No abstract available.

15.

In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjö L, Kero T, Långström B, Granstam SO, Rosengren S, Vedin O, Wassberg C, Wikström G, Westermark P, Sörensen J.

J Nucl Med. 2013 Feb;54(2):213-20. doi: 10.2967/jnumed.111.102053. Epub 2012 Dec 13.

16.

In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.

Hall H, Velikyan I, Blom E, Ulin J, Monazzam A, Påhlman L, Micke P, Wanders A, McBride W, Goldenberg DM, Långström B.

Am J Nucl Med Mol Imaging. 2012;2(2):141-50. Epub 2012 Mar 28.

17.

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.

Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, Okello A, Van Laere K, Nelissen N, Vandenbulcke M, Garibotto V, Almkvist O, Kalbe E, Hinz R, Herholz K.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):104-14. doi: 10.1007/s00259-012-2237-2. Epub 2012 Sep 8.

18.

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.

Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A.

Neurology. 2012 Jul 17;79(3):229-36. doi: 10.1212/WNL.0b013e31825fdf18. Epub 2012 Jun 13.

PMID:
22700814
19.

Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: case report with histopathological findings.

Engler H, Nennesmo I, Kumlien E, Gambini JP, Lundberg P, Savitcheva I, Långström B.

Int J Clin Exp Med. 2012;5(2):201-7. Epub 2012 Apr 6.

20.

(68)Ga-Labeling of RGD peptides and biodistribution.

Blom E, Velikyan I, Estrada S, Hall H, Muhammad T, Ding C, Nair M, Långström B.

Int J Clin Exp Med. 2012;5(2):165-72. Epub 2012 Apr 6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk